Cargando…

Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash

Erlotinib is a necessary anticancer treatment for non-small cell lung cancer (NSCLC) patients yet it causes severe side effects such as skin rash. In this study, researchers compared the untargeted compound profiles before and after erlotinib administration to observe changes in blood metabolites in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Won Kil, Myong, Jisoo, Kwag, Eunbin, Shin, Younmin, Son, Ji Woong, Yoo, Byong Chul, Kim, Byoung-Soo, Yoo, Hwa-Seung, Choi, Jeong June
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524077/ https://www.ncbi.nlm.nih.gov/pubmed/37750513 http://dx.doi.org/10.1177/15347354231198090

Ejemplares similares

Selective Immune Modulating Activities of Viscum album and Its Components; A Possibility of Therapeutics on Skin Rash Induced by EGFR Inhibitors
por: Choi, Hye Jin, et al.
Publicado: (2022)

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging
por: Nishimura, Meiko, et al.
Publicado: (2018)

Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®))
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2013)

Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness
por: Kast, R. E.
Publicado: (2015)

Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
por: Ha, Su-Jung, et al.
Publicado: (2023)

Predictive role of skin rash in advanced pancreatic cancer patients treated with gemcitabine plus erlotinib: a systematic review and meta-analysis
por: Zeng, Minyan, et al.
Publicado: (2018)

Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash
por: Hichert, Vivien, et al.
Publicado: (2017)

Erlotinib ‘dosing-to-rash’: a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
por: Mita, A C, et al.
Publicado: (2011)

Risperidone-induced skin rash
por: Janardhana, Priya, et al.
Publicado: (2016)

Febrile Illness with Skin Rashes
por: Kang, Jin Han
Publicado: (2015)

Unusual skin rash in infant
por: Alenazi, Badi, et al.
Publicado: (2017)

Aripiprazole-induced skin rash
por: Nath, Santanu, et al.
Publicado: (2016)

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
por: Van Cutsem, E, et al.
Publicado: (2014)

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study
por: Westphalen, C. Benedikt, et al.
Publicado: (2020)

Stability and Formulation of Erlotinib in Skin Creams
por: Nguyen, David, et al.
Publicado: (2022)

Icodextrin and skin rash: Unusual presentation
por: Ankur, G., et al.
Publicado: (2012)

Unusual presentation of a skin rash
por: Singh, Rajendra, et al.
Publicado: (2017)

Woman with dyspnea after skin rash
por: Yamagata, Naoki, et al.
Publicado: (2023)

Erlotinib-Associated Rash in Advanced Non-Small Cell Lung Cancer: Relation to Clinicopathological Characteristics, Treatment Response, and Survival
por: Kainis, Ilias, et al.
Publicado: (2018)

Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer
por: Lee, Jun Hwa, et al.
Publicado: (2018)

Skin rash during treatment with generic itraconazole
por: De Vuono, Antonio, et al.
Publicado: (2014)

Atypical Skin Rash in Seronegative Secondary Syphilis
por: Furuhata, Masanori, et al.
Publicado: (2016)

Acute arthritis, skin rash and Lofgren’s syndrome
por: Chauhan, Ajay, et al.
Publicado: (2021)

Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa
por: Godi, Sangha M, et al.
Publicado: (2022)

A skin rash with multiple pulmonary nodules
por: Soares Souza Jr, Arthur, et al.
Publicado: (2015)

Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation
por: Thappali, Satheeshmanikandan R. S., et al.
Publicado: (2012)

Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013)

Rash that itches and is all over: look beyond the skin
por: Lohani, Saroj, et al.
Publicado: (2016)

A Desquamating Skin Rash in a Pediatric Patient
por: Haggerty, John, et al.
Publicado: (2019)

Peculiar Skin Rash After Laparoscopic Sleeve Gastrectomy
por: Eghleilib, Mohamed, et al.
Publicado: (2020)

Segmental Zoster Abdominal Paresis without Skin Rash
por: Hashimoto, Tadayuki, et al.
Publicado: (2020)

Moderna COVID-19 vaccine induced skin rash
por: Khalid, Muhamad, et al.
Publicado: (2021)

Tozinameran: Erythematous skin rash with blisters : case report
Publicado: (2022)

Antineoplastics: Leucopenia, skin rash and pruritus: case report
Publicado: (2022)

Reticular Skin Rash as an Adverse Effect of 5-Azacitidine
por: Verma, Parul, et al.
Publicado: (2022)

Skin rash, dyspnea and bone pain: secondary syphilis
por: Manríquez, Juan, et al.
Publicado: (2014)

Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions
por: Schutte, Tim, et al.
Publicado: (2023)

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Identification of CEA-interacting proteins in colon cancer cells and their changes in expression after irradiation
por: Yoo, Byong Chul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dq9902josf66h91ulsohketqai